난치성 당뇨 족부 궤양에 대한 임상적 고찰: 치료에 영향을 미치는 인자 분석
Clinical Analysis of Intractable Diabetic Foot Ulcers: Accessing Risk Factors
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Diabetic foot ulcer is one of the most important diabetic complications because it increases the risk of amputations. Moreover, it lowers the quality of patients’ life and increases the social medical expenses. Authors analyzed risk factors of intractable diabetic foot ulcer using retrospective study. Materials and Methods: From January 2007 to December 2010, 40 patients who could not achieve complete healing despite more than 12 weeks of proper management among who had been diagnosed and treated as diabetic foot ulcer at our hospital were included and evaluated retrospectively. We compared the risk factors between two groups who were finally treated by amputation and non-amputation. Results: The sample was composed of 31 male patients (77.5%) and 9 female patients (22.5%). Comorbidity including hypertension and hyperlipidemia were 77.5% and 80% each. By Wagner classification, 30 patients (80%) had ulcerative lesion over the grade 3. From bacteriology results, 29 patients (72.5%) had polybacteria infection. 35 patients (87.5%) had neuropathy and 26 patients (65%) had vascular stenosis at least one level. The mean initial ankle-brachial index and toe-brachial index were 0.982 and 0.439. In comparison between amputation group and non-amputation group, ulcer severity, number of stenotic vessel and initial ankle-brachial index/toe-brachial index had statistical significance. Conclusion: The most commonly risk factor of intractable diabetic foot ulcer was peripheral neuropathy reaching 87.5% of cases. In comparison with non-amputation group, ulcer severity according to Wagner classification, number of stenotic vessel and initial ankle-brachial index/toe-brachial index were demonstrated as a risk factor of amputation in intractable diabetic foot ulcer.
Abstract
Purpose: Diabetic foot ulcer is one of the most important diabetic complications because it increases the risk of amputations. Moreover, it lowers the quality of patients’ life and increases the social medical expenses. Authors analyzed risk factors of intractable diabetic foot ulcer using retrospective study. Materials and Methods: From January 2007 to December 2010, 40 patients who could not achieve complete healing despite more than 12 weeks of proper management among who had been diagnosed and treated as diabetic foot ulcer at our hospital were included and evaluated retrospectively. We compared the risk factors between two groups who were finally treated by amputation and non-amputation. Results: The sample was composed of 31 male patients (77.5%) and 9 female patients (22.5%). Comorbidity including hypertension and hyperlipidemia were 77.5% and 80% each. By Wagner classification, 30 patients (80%) had ulcerative lesion over the grade 3. From bacteriology results, 29 patients (72.5%) had polybacteria infection. 35 patients (87.5%) had neuropathy and 26 patients (65%) had vascular stenosis at least one level. The mean initial ankle-brachial index and toe-brachial index were 0.982 and 0.439. In comparison between amputation group and non-amputation group, ulcer severity, number of stenotic vessel and initial ankle-brachial index/toe-brachial index had statistical significance. Conclusion: The most commonly risk factor of intractable diabetic foot ulcer was peripheral neuropathy reaching 87.5% of cases. In comparison with non-amputation group, ulcer severity according to Wagner classification, number of stenotic vessel and initial ankle-brachial index/toe-brachial index were demonstrated as a risk factor of amputation in intractable diabetic foot ulcer.
참고문헌 (25)
- Danaei G, "National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants", Lancet, 378, pp.31~40 (2011)
- Heo KB, "A clinical study in patients with diabetic gangrene", J Kor Diabetes Assoc, 7, pp.65~70 (1983)
- Boulton AJ, "Foot problems in patients with diabetes mellitus. In Textbook of diabetes. 2nd ed", pp.1~20 (1997), Blackwell Science
- Ramsey SD, "Incidence, outcomes and cost of foot ulcers in patients with diabetes", Diabetes Care, 22, pp.382~387 (1999)
- Most RS, "The epidemiology of lower extremity amputation in diabetic individuals", Diabetes Care, 6, pp.87~91 (1983)
- Waugh NR, "Amputation in diabetic patients--a review of rates, relative risks and resource use", Community Med, 10, pp.279~288 (1988)
- Levin ME, "Pathophysiology of diabetic foot lesions. In Clinical diabetes mellitus: a problem-oriented approach. 3rd ed", pp.581~598 (1999), Thieme
- Siitonen OI, "Lower-extremity amputations in diabetic and nondiabetic patients. A population-based study in eastern Finland", Diabetes Care, 16, pp.16~20 (1993)
- 정춘희, "우리나라 당뇨병성 족부질환의 현황: 건강보험자료 분석결과", Diabetes and Metabolism Journal, 30(5), pp.372~376 (2006), 대한당뇨병학회
- Yamaguchi Y, , B J Dermatol, 151, pp.1019~1028 (2004)
- Kim YJ, "Clinical analysis of diabetic gangrene", J Korean Orthop Asso, 24, pp.946~953 (1989)
- Humphrey CC, "The contribution of non-insulin-dependent diabetes to lower-extremity amputation in the community", Arch Intern Med, 154, pp.885~892 (1994)
- Boyko EJ, "A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study", Diabetes Care, 22, pp.1036~1042 (1999)
- Adler AI, "Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers", Diabetes Care, 22, pp.1029~1035 (1999)
- Shimoshige Y, "The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats", Metabolism, 49, pp.1395~1399 (2000)
- Sundkvist G, "Sorbitol and myo-inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance", Diabet Med, 17, pp.259~268 (2000)
- Brownlee M, "Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking", Science, 232, pp.1629~1632 (1986)
- Kent MJ, "Evidence for glucose-mediated covalent cross-linking of colagen after glycosylation in vitro", Biochem J, 225, pp.745~752 (1985)
- Vernino S, "Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies", N Engl J Med, 343, pp.847~855 (2000)
- Morano S, "Autoimmune markers and neurological complications in non-insulin-dependent diabetes mellitus", Hum Immunol, 60, pp.848~854 (1999)
- Benotmane A, "Diabetic foot lesions: etiologic and prognostic factors", Diabetes Metab, 26, pp.133~137 (2000)
- Khdler Y, "Shear stress abnormalities contribute to endothelial dysfunction in hypertension but not in type II diabetes", J Hypertens, 16, pp.1619~1625 (1998)
- Reiber GE, "Preventing foot ulcers and amputations in diabetes", Lancet, 366, pp.1676~1677 (2005)
- Lipsky BA, "Developing and validating a risk score for lower- extremity amputation in patients hospitalized for a diabetic foot infection", Diabetes Care, 34, pp.1695~1700 (2011)
- Cosentino F, "Endothelial dysfunction in diabetes mellitus", J Cardiovasc Pharmacol, 32(3), pp.54~61 (1998)